Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and/or hormonal therapy and clinicopathologic features of GATA-3-positive tumors.

[1]  Jason Wang,et al.  GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance. , 2013, Human pathology.

[2]  Siyu Sun,et al.  Cell cycle-dependent deposition of CENP-A requires the Dos1/2–Cdc20 complex , 2012, Proceedings of the National Academy of Sciences.

[3]  Y. Tamaki,et al.  Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  C. Forster,et al.  Concordance Between Tissue Microarray and Whole-section Estrogen Receptor Expression and Intratumoral Heterogeneity , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[5]  Fang Liu,et al.  Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy. , 2011, Cancer letters.

[6]  Steve Horvath,et al.  Higher levels of GATA3 predict better survival in women with breast cancer. , 2010, Human pathology.

[7]  S. Badve,et al.  Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model. , 2010, Oncology reports.

[8]  S. Badve,et al.  Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores , 2010, Modern Pathology.

[9]  J. Palazzo,et al.  The significance of GATA3 expression in breast cancer: a 10-year follow-up study. , 2009, Human pathology.

[10]  T. Nielsen,et al.  GATA-3 Expression in Breast Cancer Has a Strong Association with Estrogen Receptor but Lacks Independent Prognostic Value , 2008, Cancer Epidemiology Biomarkers & Prevention.

[11]  Jérôme Eeckhoute,et al.  Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor α Expression in Breast Cancer , 2007 .

[12]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[13]  Debashis Ghosh,et al.  Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. , 2005, Cancer research.

[14]  J. Eeckhoute,et al.  Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. , 2007, Cancer research.